Related references
Note: Only part of the references are listed.Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D. Beitsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients
Nadine M. Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ACR Appropriateness Criteria ® Breast Cancer Screening
Martha B. Mainiero et al.
Journal of the American College of Radiology (2017)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe et al.
JAMA ONCOLOGY (2015)
Inherited predisposition to breast cancer among African American women
Jane E. Churpek et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
US Breast Cancer Mortality Trends in Young Women According to Race
Foluso O. Ademuyiwa et al.
CANCER (2015)
Population-Based Screening for BRCA1 and BRCA2 2014 Lasker Award
Mary-Claire King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Early Onset Breast Cancer in a Registry-based Sample of African-American Women: BRCA Mutation Prevalence, and Other Personal and System-level Clinical Characteristics
Tuya Pal et al.
BREAST JOURNAL (2013)
Disparities in breast cancer characteristics and outcomes by race/ethnicity
Siew Loon Ooi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K. Metcalfe et al.
BRITISH JOURNAL OF CANCER (2011)
Genomics for the world
Carlos D. Bustamante et al.
NATURE (2011)
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
B. G. Haffty et al.
ANNALS OF ONCOLOGY (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Next generation disparities in human genomics: concerns and remedies
Anna C. Need et al.
TRENDS IN GENETICS (2009)
Strategies and stakeholders: Minority recruitment in cancer genetics research
Rosalina D. James et al.
COMMUNITY GENETICS (2008)
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D. Fackenthal et al.
NATURE REVIEWS CANCER (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer
CK Kuhl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Genetic testing in an ethnically diverse cohort of high-risk women -: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry
R Nanda et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
MO Leach et al.
LANCET (2005)
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
CD Lehman et al.
CANCER (2005)
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
K Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination
E Warner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Polygenic susceptibility to breast cancer and implications for prevention
PDP Pharoah et al.
NATURE GENETICS (2002)
Estimates of the likely prophylactic with high risk BRCA1 and BRCA2 effect of tamoxifen in women mutations
SW Duffy et al.
BRITISH JOURNAL OF CANCER (2002)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
